| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919716 | Radiotherapy and Oncology | 2011 | 8 Pages |
Abstract
Combined EGFR/FAK targeting yielded stronger radiosensitization than either approach alone, which might be based on non-overlapping downstream signaling. Whether dual targeting of EGFR and FAK can reasonably be combined with radiotherapy and chemotherapy needs clarification.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Iris Eke, Nils Cordes,